search
Back to results

Assistive Soft Robotic Glove (EsoGLOVE) Intervention for Stroke Patients

Primary Purpose

Stroke

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
EsoGLOVE with Trigno Biofeedback (EMG sensors)
Sponsored by
National University Hospital, Singapore
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring stroke, soft robotics, upper limb rehabilitation

Eligibility Criteria

30 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 30-90 years regardless of lesion size, race
  • Stroke type: ischemic or haemorrhagic
  • Medically stable conditions
  • Fugl-Meyer Assessment (FMA) of upper extremity impairment of 10-56 out of 66.
  • Able to give own consent, comprehend and follow commands
  • Able to sit upright and maintain sitting balance for at least 30 minutes
  • Able to stay alert and focus on the tasks for at least 30 minutes and more.
  • Unilateral upper limb impairment

Exclusion Criteria:

  • Recurrent stroke
  • Unstable medical conditions (e.g. heart attack, unstable blood pressure, infection, and etc.) or anticipated life expectancy of <1 year.
  • Cognitive and communicative impairment (e.g. severe aphasia, inattention, learning difficulty, and etc).
  • History of severe depression or active psychiatric disorder.
  • Severe spasticity (Modified Ashworth scale =2), joint contractures or deformity, poor skin conditions (e.g. irritated skin, open wounds), amputation of fingers, and allergic condition (e.g. patients with allergies to adhesive gel).
  • Poor trunk control or postural hypotension.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    EsoGLOVE with Trigno Biofeedback (EMG sensors) group

    GRASP group

    Arm Description

    The subjects will receive the intervention (EsoGLOVE with Trigno Biofeedback (EMG sensors) treatment with Trigno Biofeedback (EMG sensors) on therapy day (Monday to Friday) for 3 weeks, a minimum of 30 minutes per day, in addition to intensive stroke rehabilitation as per normal, which will be daily physiotherapy and occupational therapy as a part of standard care as per stroke rehabilitation.

    Graded Repetitive Arm Supplementary Program (GRASP) following the GRASP protocolwhile wearing a neoprene wrist support) on therapy day (Monday to Friday) for 3 weeks, a minimum of 30 minutes per day, in addition to intensive stroke rehabilitation as per normal, which will be daily physiotherapy and occupational therapy as a part of standard care as per stroke rehabilitation.

    Outcomes

    Primary Outcome Measures

    Fugl-Meyer Upper Extremity Scale (FML-UE)
    The Fugl-Meyer Upper Extremity (FMUE) is a 33 item scale used for assessing reflex activity, movement control and muscle strength in the upper extremity of people with post-stroke hemiplegia. Each item is scored from 0 to 2, where 0 = cannot perform, 1 = performs partially and2 = performs fully. Total scores for all items ranges form 0 to 66, where higher scores indicates better functioning of the upper limb and lower scores indicates decreased function in the affected upper limb. The FML-UE scale is administered at different time points to track patients' improvements of the affected upper limb in stroke patients.
    Fugl-Meyer Upper Extremity Scale (FML-UE)
    The Fugl-Meyer Upper Extremity (FMUE) is a 33 item scale used for assessing reflex activity, movement control and muscle strength in the upper extremity of people with post-stroke hemiplegia. Each item is scored from 0 to 2, where 0 = cannot perform, 1 = performs partially and2 = performs fully. Total scores for all items ranges form 0 to 66, where higher scores indicates better functioning of the upper limb and lower scores indicates decreased function in the affected upper limb. The FML-UE scale is administered at different time points to track patients' improvements of the affected upper limb in stroke patients.
    Fugl-Meyer Upper Extremity Scale (FML-UE)
    The Fugl-Meyer Upper Extremity (FMUE) is a 33 item scale used for assessing reflex activity, movement control and muscle strength in the upper extremity of people with post-stroke hemiplegia. Each item is scored from 0 to 2, where 0 = cannot perform, 1 = performs partially and2 = performs fully. Total scores for all items ranges form 0 to 66, where higher scores indicates better functioning of the upper limb and lower scores indicates decreased function in the affected upper limb. The FML-UE scale is administered at different time points to track patients' improvements of the affected upper limb in stroke patients.
    Stroke Impact Scale (SIS)
    The Stroke Impact Scale (SIS) is a 59 item, self-reporting questionnaire for assessing disability and health-related quality of life (QoL) after stroke in 8 domains, namely: 1. Strength, 2. Hand function, 3. Activities of daily living (ADL/IADL), 4. Mobility, 5. Communication, 6. Emotion, 7. Memory and thinking, 8. Participation/Role function. The individual items are total scores to give a range of 0 to 100, where higher scores indicates better functioning.
    Stroke Impact Scale (SIS)
    The Stroke Impact Scale (SIS) is a 59 item, self-reporting questionnaire for assessing disability and health-related quality of life (QoL) after stroke in 8 domains, namely: 1. Strength, 2. Hand function, 3. Activities of daily living (ADL/IADL), 4. Mobility, 5. Communication, 6. Emotion, 7. Memory and thinking, 8. Participation/Role function. The individual items are total scores to give a range of 0 to 100, where higher scores indicates better functioning.
    Stroke Impact Scale (SIS)
    The Stroke Impact Scale (SIS) is a 59 item, self-reporting questionnaire for assessing disability and health-related quality of life (QoL) after stroke in 8 domains, namely: 1. Strength, 2. Hand function, 3. Activities of daily living (ADL/IADL), 4. Mobility, 5. Communication, 6. Emotion, 7. Memory and thinking, 8. Participation/Role function. The individual items are total scores to give a range of 0 to 100, where higher scores indicates better functioning and is administered at different time points to track improvements in patients.
    Duruoz Hand Index
    The Duruoz Hand Index is a 18-item self-reporting questionnaire for evaluating activity limitations of the hand in terms of level of difficulties in carrying out manual tasks independently in 5 domains, namely: 1. in the kitchen, 2. dressing, 3. hygiene, 4. in the, office and 5. Other. Each item is rated on a 6 point Likert scale, where 0 = without difficulty and 5 = impossible. All the responses are totaled score of between 0 to 90 where higher scores represents poorer functioning of the affected hand. The Duroz Hand Index is administered at different time points to track improvements in the patient's level of functioning.
    Duruoz Hand Index
    The Duruoz Hand Index is a 18-item self-reporting questionnaire for evaluating activity limitations of the hand in terms of level of difficulties in carrying out manual tasks independently in 5 domains, namely: 1. in the kitchen, 2. dressing, 3. hygiene, 4. in the, office and 5. Other. Each item is rated on a 6 point Likert scale, where 0 = without difficulty and 5 = impossible. All the responses are totaled score of between 0 to 90 where higher scores represents poorer functioning of the affected hand. The Duroz Hand Index is administered at different time points to track improvements in the patient's level of functioning.
    Duruoz Hand Index
    The Duruoz Hand Index is a 18-item self-reporting questionnaire for evaluating activity limitations of the hand in terms of level of difficulties in carrying out manual tasks independently in 5 domains, namely: 1. in the kitchen, 2. dressing, 3. hygiene, 4. in the, office and 5. Other. Each item is rated on a 6 point Likert scale, where 0 = without difficulty and 5 = impossible. All the responses are totaled score of between 0 to 90 where higher scores represents poorer functioning of the affected hand. The Duroz Hand Index is administered at different time points to track improvements in the patient's level of functioning.
    Stroke Upper Limb Capacity Scale (SULCS)
    The SULCS consists of 10 tasks that relate to daily activities.1,3 Each receives a score of 0 (unable to perform) or 1 (able to perform), resulting in a total score of 0-10 where higher scores indicates better functioning of the stroke-affected upper limb. This scale is administered at different time points to assess the improvements in upper limb affected by stroke.
    Stroke Upper Limb Capacity Scale (SULCS)
    The SULCS consists of 10 tasks that relate to daily activities.1,3 Each receives a score of 0 (unable to perform) or 1 (able to perform), resulting in a total score of 0-10 where higher scores indicates better functioning of the stroke-affected upper limb. This scale is administered at different time points to assess the improvements in upper limb affected by stroke.
    Stroke Upper Limb Capacity Scale (SULCS)
    The SULCS consists of 10 tasks that relate to daily activities.1,3 Each receives a score of 0 (unable to perform) or 1 (able to perform), resulting in a total score of 0-10 where higher scores indicates better functioning of the stroke-affected upper limb. This scale is administered at different time points to assess the improvements in upper limb affected by stroke.
    Out-of-Pocket Spending Questionnaire
    Out-of-Pocket Spending is defined as direct payments made by individuals to health care providers at the time of service use. The Out-of-Pocket Spending Questionnaire will record out-of-pocket spending the patient has made from Week 3 to 12.

    Secondary Outcome Measures

    Full Information

    First Posted
    August 8, 2022
    Last Updated
    August 8, 2022
    Sponsor
    National University Hospital, Singapore
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05494489
    Brief Title
    Assistive Soft Robotic Glove (EsoGLOVE) Intervention for Stroke Patients
    Official Title
    Assistive Soft Robotic Glove (EsoGLOVE) Intervention for Stroke Patients
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    August 15, 2022 (Anticipated)
    Primary Completion Date
    June 29, 2023 (Anticipated)
    Study Completion Date
    June 29, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    National University Hospital, Singapore

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Stroke remains the 4th cause of death in Singapore and despite advances in medical care and rehabilitation, 40-50% of stroke survivors are left with permanent disability and reduced quality of life. Hand motor impairment is a very serious complication to every stroke survivor. These impairments include difficulty moving and coordinating the hands and fingers, which inhibits stroke patients from being able to perform daily functional tasks independently, resulting in a reduced quality of life. More than half of people with upper limb impairment after stroke will still have problems many months to years after their stroke. Therefore, improving hand function is a core element of rehabilitation where the aim is to recover and recruit the damaged neurons in the brain as soon as possible, within 3-6 months of the stroke as it thought to be the golden recovery period. In the hospital setting, every stroke patient will receive about 30 minutes to 1 hour of occupational therapy (OT) for functional training, including hand functional exercises. However, manpower constraints limited stroke patients to one OT session per day but they are encouraged to continuously practice on their own, which may cause patients to encounter difficulties without guidance and hence less motivated to perform. This proposed research aims to assess the efficacy and feasibility of the EsoGLOVE with Trigno Biofeedback (EMG sensors) in the inpatient rehabilitation setting through: Understanding the ability of the EsoGLOVE with Trigno Biofeedback (EMG sensors) in providing CPM exercise and assisting stroke patients with completing hand functional tasks, eventually improves patients' motor function and neural recovery. To generate evidence on this innovative device and further deploy it in clinical practice. A Health Technology Assessment (HTA) will be generated from this study to evaluate the cost-effectiveness of the intervention. The investigators hypothesize that EsoGLOVE with Trigno Biofeedback (EMG sensors) combined with hand rehabilitation will add additional benefits to stroke patients. It might have better hand functional outcomes than hand rehabilitation alone as it can allow the patients to conduct functional task training in both passive and active modes.
    Detailed Description
    Stroke remains the 4th cause of death in Singapore and despite advances in medical care and rehabilitation, 40-50% of stroke survivors are left with permanent disability and reduced quality of life. Given a global aging population and growing manpower constraints, the therapists-to-patients ratio will likely be inadequate. In the local context, Singapore is moving towards an aging population, where the number of elderly is expected to triple to 900,000 by 2030 with a decreasing old-age support ratio and is likely to be associated with increased risk of stroke and related motor disabilities. Hand motor impairment is a very serious complication to every stroke survivor. These impairments include difficulty moving and coordinating the hands and fingers, which inhibits stroke patients from being able to perform daily functional tasks independently, resulting in a reduced quality of life. More than half of people with upper limb impairment after stroke will still have problems many months to years after their stroke. Therefore, improving hand function is a core element of rehabilitation. Early rehabilitation is very essential to acute stroke patients. Most of the patients receive early rehabilitation in acute hospital and community hospital after suffering the stroke. The aim is to recover and recruit the damaged neurons in the brain as soon as possible. People believe that patients should start intensive rehabilitation within 3-6 months as the golden recovery period. In the hospital setting, every stroke patient will receive occupational therapy for functional training, including hand functional exercises. One therapy session is about 30 minutes to 1 hour. Due to manpower constraints, stroke patients may receive one session per day only. Patients may rest in the ward or the bed whole day after the therapy session. Bed exercises may be provided by therapists and encouraging patients to continuously practice while resting in the bed, however, patients may feel difficult without guidance and low motivation to perform. Hence this research is important for: Assessing the efficacy of the EsoGLOVE with Trigno Biofeedback (EMG sensors) for acute and subacute stroke patients in the inpatient rehabilitation setting. Investigating the efficacy of the EsoGLOVE with Trigno Biofeedback (EMG sensors): To achieve a minimum of 6 FMA scores difference/change between treatments and pre amp; post-intervention (3rd -0th week). Understanding the ability and clinical outcome of the EsoGLOVE with Trigno Biofeedback (EMG sensors) in providing CPM exercise and assisting stroke patients with completing hand functional tasks, eventually improve patients' motor function and neural recovery. Generating evidence on this innovative device and further deploy it in clinical practice. A Health Technology Assessment (HTA) will be generated from this study to evaluate the cost-effectiveness of the intervention. This proposed research aims to assess the efficacy and feasibility of the EsoGLOVE with Trigno Biofeedback (EMG sensors) in the inpatient rehabilitation setting through: Understanding the ability of the EsoGLOVE with Trigno Biofeedback (EMG sensors) in providing CPM exercise and assisting stroke patients with completing hand functional tasks, eventually improves patients' motor function and neural recovery. To generate evidence on this innovative device and further deploy it in clinical practice. A Health Technology Assessment (HTA) will be generated from this study to evaluate the cost-effectiveness of the intervention. The investigators hypothesize that EsoGLOVE with Trigno Biofeedback (EMG sensors) combined with hand rehabilitation will add additional benefits to stroke patients. It might have better hand functional outcomes than hand rehabilitation alone as it can allow the patients to conduct functional task training in both passive and active modes.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Stroke
    Keywords
    stroke, soft robotics, upper limb rehabilitation

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Randomised controlled trial, single blind (Assessor blinded)
    Masking
    Outcomes Assessor
    Masking Description
    The randomization method: A block randomization with a randomly varying block size. [Online] Available from: https://www.sealedenvelope.com/simple-randomiser/v1/lists [Accessed 14 Oct 2020].
    Allocation
    Randomized
    Enrollment
    130 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    EsoGLOVE with Trigno Biofeedback (EMG sensors) group
    Arm Type
    Experimental
    Arm Description
    The subjects will receive the intervention (EsoGLOVE with Trigno Biofeedback (EMG sensors) treatment with Trigno Biofeedback (EMG sensors) on therapy day (Monday to Friday) for 3 weeks, a minimum of 30 minutes per day, in addition to intensive stroke rehabilitation as per normal, which will be daily physiotherapy and occupational therapy as a part of standard care as per stroke rehabilitation.
    Arm Title
    GRASP group
    Arm Type
    Active Comparator
    Arm Description
    Graded Repetitive Arm Supplementary Program (GRASP) following the GRASP protocolwhile wearing a neoprene wrist support) on therapy day (Monday to Friday) for 3 weeks, a minimum of 30 minutes per day, in addition to intensive stroke rehabilitation as per normal, which will be daily physiotherapy and occupational therapy as a part of standard care as per stroke rehabilitation.
    Intervention Type
    Device
    Intervention Name(s)
    EsoGLOVE with Trigno Biofeedback (EMG sensors)
    Intervention Description
    The EsoGLOVE + Trigno subjects will receive EsoGLOVE with Trigno Biofeedback (EMG sensors) training on therapy day for 3 weeks (week 1 to week 3, sessions will be done every Monday to Friday), a minimum of 30 minutes per day in additional to the physiotherapy and occupational therapy as standard care for stroke patients.
    Primary Outcome Measure Information:
    Title
    Fugl-Meyer Upper Extremity Scale (FML-UE)
    Description
    The Fugl-Meyer Upper Extremity (FMUE) is a 33 item scale used for assessing reflex activity, movement control and muscle strength in the upper extremity of people with post-stroke hemiplegia. Each item is scored from 0 to 2, where 0 = cannot perform, 1 = performs partially and2 = performs fully. Total scores for all items ranges form 0 to 66, where higher scores indicates better functioning of the upper limb and lower scores indicates decreased function in the affected upper limb. The FML-UE scale is administered at different time points to track patients' improvements of the affected upper limb in stroke patients.
    Time Frame
    Baseline assessment
    Title
    Fugl-Meyer Upper Extremity Scale (FML-UE)
    Description
    The Fugl-Meyer Upper Extremity (FMUE) is a 33 item scale used for assessing reflex activity, movement control and muscle strength in the upper extremity of people with post-stroke hemiplegia. Each item is scored from 0 to 2, where 0 = cannot perform, 1 = performs partially and2 = performs fully. Total scores for all items ranges form 0 to 66, where higher scores indicates better functioning of the upper limb and lower scores indicates decreased function in the affected upper limb. The FML-UE scale is administered at different time points to track patients' improvements of the affected upper limb in stroke patients.
    Time Frame
    Post-intervention assessment at day 15.
    Title
    Fugl-Meyer Upper Extremity Scale (FML-UE)
    Description
    The Fugl-Meyer Upper Extremity (FMUE) is a 33 item scale used for assessing reflex activity, movement control and muscle strength in the upper extremity of people with post-stroke hemiplegia. Each item is scored from 0 to 2, where 0 = cannot perform, 1 = performs partially and2 = performs fully. Total scores for all items ranges form 0 to 66, where higher scores indicates better functioning of the upper limb and lower scores indicates decreased function in the affected upper limb. The FML-UE scale is administered at different time points to track patients' improvements of the affected upper limb in stroke patients.
    Time Frame
    Post-intervention assessment at 3 month follow up visit
    Title
    Stroke Impact Scale (SIS)
    Description
    The Stroke Impact Scale (SIS) is a 59 item, self-reporting questionnaire for assessing disability and health-related quality of life (QoL) after stroke in 8 domains, namely: 1. Strength, 2. Hand function, 3. Activities of daily living (ADL/IADL), 4. Mobility, 5. Communication, 6. Emotion, 7. Memory and thinking, 8. Participation/Role function. The individual items are total scores to give a range of 0 to 100, where higher scores indicates better functioning.
    Time Frame
    Baseline assessment
    Title
    Stroke Impact Scale (SIS)
    Description
    The Stroke Impact Scale (SIS) is a 59 item, self-reporting questionnaire for assessing disability and health-related quality of life (QoL) after stroke in 8 domains, namely: 1. Strength, 2. Hand function, 3. Activities of daily living (ADL/IADL), 4. Mobility, 5. Communication, 6. Emotion, 7. Memory and thinking, 8. Participation/Role function. The individual items are total scores to give a range of 0 to 100, where higher scores indicates better functioning.
    Time Frame
    Post-intervention assessment at 21 days
    Title
    Stroke Impact Scale (SIS)
    Description
    The Stroke Impact Scale (SIS) is a 59 item, self-reporting questionnaire for assessing disability and health-related quality of life (QoL) after stroke in 8 domains, namely: 1. Strength, 2. Hand function, 3. Activities of daily living (ADL/IADL), 4. Mobility, 5. Communication, 6. Emotion, 7. Memory and thinking, 8. Participation/Role function. The individual items are total scores to give a range of 0 to 100, where higher scores indicates better functioning and is administered at different time points to track improvements in patients.
    Time Frame
    Post-intervention assessment at 3 months follow-up
    Title
    Duruoz Hand Index
    Description
    The Duruoz Hand Index is a 18-item self-reporting questionnaire for evaluating activity limitations of the hand in terms of level of difficulties in carrying out manual tasks independently in 5 domains, namely: 1. in the kitchen, 2. dressing, 3. hygiene, 4. in the, office and 5. Other. Each item is rated on a 6 point Likert scale, where 0 = without difficulty and 5 = impossible. All the responses are totaled score of between 0 to 90 where higher scores represents poorer functioning of the affected hand. The Duroz Hand Index is administered at different time points to track improvements in the patient's level of functioning.
    Time Frame
    Baseline assessment
    Title
    Duruoz Hand Index
    Description
    The Duruoz Hand Index is a 18-item self-reporting questionnaire for evaluating activity limitations of the hand in terms of level of difficulties in carrying out manual tasks independently in 5 domains, namely: 1. in the kitchen, 2. dressing, 3. hygiene, 4. in the, office and 5. Other. Each item is rated on a 6 point Likert scale, where 0 = without difficulty and 5 = impossible. All the responses are totaled score of between 0 to 90 where higher scores represents poorer functioning of the affected hand. The Duroz Hand Index is administered at different time points to track improvements in the patient's level of functioning.
    Time Frame
    Post-intervention assessment at 21 days
    Title
    Duruoz Hand Index
    Description
    The Duruoz Hand Index is a 18-item self-reporting questionnaire for evaluating activity limitations of the hand in terms of level of difficulties in carrying out manual tasks independently in 5 domains, namely: 1. in the kitchen, 2. dressing, 3. hygiene, 4. in the, office and 5. Other. Each item is rated on a 6 point Likert scale, where 0 = without difficulty and 5 = impossible. All the responses are totaled score of between 0 to 90 where higher scores represents poorer functioning of the affected hand. The Duroz Hand Index is administered at different time points to track improvements in the patient's level of functioning.
    Time Frame
    Post-intervention assessment 3 months follow up
    Title
    Stroke Upper Limb Capacity Scale (SULCS)
    Description
    The SULCS consists of 10 tasks that relate to daily activities.1,3 Each receives a score of 0 (unable to perform) or 1 (able to perform), resulting in a total score of 0-10 where higher scores indicates better functioning of the stroke-affected upper limb. This scale is administered at different time points to assess the improvements in upper limb affected by stroke.
    Time Frame
    Baseline assessment
    Title
    Stroke Upper Limb Capacity Scale (SULCS)
    Description
    The SULCS consists of 10 tasks that relate to daily activities.1,3 Each receives a score of 0 (unable to perform) or 1 (able to perform), resulting in a total score of 0-10 where higher scores indicates better functioning of the stroke-affected upper limb. This scale is administered at different time points to assess the improvements in upper limb affected by stroke.
    Time Frame
    Post-intervention assessment at 21 days follow up
    Title
    Stroke Upper Limb Capacity Scale (SULCS)
    Description
    The SULCS consists of 10 tasks that relate to daily activities.1,3 Each receives a score of 0 (unable to perform) or 1 (able to perform), resulting in a total score of 0-10 where higher scores indicates better functioning of the stroke-affected upper limb. This scale is administered at different time points to assess the improvements in upper limb affected by stroke.
    Time Frame
    Post-intervention assessment at 3 months follow up
    Title
    Out-of-Pocket Spending Questionnaire
    Description
    Out-of-Pocket Spending is defined as direct payments made by individuals to health care providers at the time of service use. The Out-of-Pocket Spending Questionnaire will record out-of-pocket spending the patient has made from Week 3 to 12.
    Time Frame
    Post-intervention assessment at 3 month follow up visit only

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    30 Years
    Maximum Age & Unit of Time
    90 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Aged 30-90 years regardless of lesion size, race Stroke type: ischemic or haemorrhagic Medically stable conditions Fugl-Meyer Assessment (FMA) of upper extremity impairment of 10-56 out of 66. Able to give own consent, comprehend and follow commands Able to sit upright and maintain sitting balance for at least 30 minutes Able to stay alert and focus on the tasks for at least 30 minutes and more. Unilateral upper limb impairment Exclusion Criteria: Recurrent stroke Unstable medical conditions (e.g. heart attack, unstable blood pressure, infection, and etc.) or anticipated life expectancy of <1 year. Cognitive and communicative impairment (e.g. severe aphasia, inattention, learning difficulty, and etc). History of severe depression or active psychiatric disorder. Severe spasticity (Modified Ashworth scale =2), joint contractures or deformity, poor skin conditions (e.g. irritated skin, open wounds), amputation of fingers, and allergic condition (e.g. patients with allergies to adhesive gel). Poor trunk control or postural hypotension.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Pui Kit Tam, MD
    Phone
    +65 8481 7399
    Email
    pui_kit_tam@nuhs.edu.sg
    First Name & Middle Initial & Last Name or Official Title & Degree
    serene Huang, MN
    Phone
    +65 83998743
    Email
    serene_huang@nuhs.edu.sg
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Pui Kit Tam, MD
    Organizational Affiliation
    National University Hospital, Singapore
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    32248089
    Citation
    Cheng N, Phua KS, Lai HS, Tam PK, Tang KY, Cheng KK, Yeow RC, Ang KK, Guan C, Lim JH. Brain-Computer Interface-Based Soft Robotic Glove Rehabilitation for Stroke. IEEE Trans Biomed Eng. 2020 Dec;67(12):3339-3351. doi: 10.1109/TBME.2020.2984003. Epub 2020 Nov 19.
    Results Reference
    background
    PubMed Identifier
    31325644
    Citation
    Nasrallah FA, Mohamed AZ, Campbell ME, Yap HK, Yeow CH, Lim JH. Functional connectivity of brain associated with passive range of motion exercise: Proprioceptive input promoting motor activation? Neuroimage. 2019 Nov 15;202:116023. doi: 10.1016/j.neuroimage.2019.116023. Epub 2019 Jul 17.
    Results Reference
    background
    PubMed Identifier
    29062267
    Citation
    Yap HK, Lim JH, Nasrallah F, Yeow CH. Design and Preliminary Feasibility Study of a Soft Robotic Glove for Hand Function Assistance in Stroke Survivors. Front Neurosci. 2017 Oct 9;11:547. doi: 10.3389/fnins.2017.00547. eCollection 2017. Erratum In: Front Neurosci. 2018 May 08;12 :323.
    Results Reference
    background

    Learn more about this trial

    Assistive Soft Robotic Glove (EsoGLOVE) Intervention for Stroke Patients

    We'll reach out to this number within 24 hrs